Aspirin and cancer: the emerging evidence

Professor Peter Elwood Honorary Professor, Cardiff University There is a remarkable harmony between the effects of aspirin on the biological mechanisms of cancer metabolism and growth, and clinical evidence of reductions in cancer mortality and metastatic cancer spread. Although aspirin increases the number of bleeds, the severity of bleeds attributable to aspirin is low, and the risk-benefit balance of aspirin appears to be favourable to aspirin. Find out more about our Science in Health Public Lecture Series by visiting